Without Graphite, There Would Be ZERO EV Batteries!
Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients.
See This Special Report to Get the Full Story
Michelle Keefe net worth and biography

Michelle Keefe Biography and Net Worth

Insider of Syneos Health

Ms. Keefe brings more than 30 years of life science expertise to her role as Chief Executive Officer. She joined Syneos Health in 2017, serving as President of Medical Affairs and Commercial Solutions for more than four years, overseeing multi-disciplinary teams including Medical Affairs, Real World Evidence, Full-Service Commercial, Deployment Solutions, Communications and Consulting. During this time, her work across the product development continuum included launching Kinetic™, Syneos Health’s modern customer engagement capability, building integrated solutions such as Full-Service Commercial and Medical Affairs, and collaborating to drive growth in Syneos One, the Company’s unique end-to-end offering.

Prior to Syneos Health, Ms. Keefe served as Global Group President and Chief Development Officer of Publicis Health, responsible for the Contract Sales Organization (CSO), medical affairs and specialty agency functions. Earlier in her career, she spent 20 years at Pfizer, with increasing levels of responsibility culminating as a Regional President, and led market development for the Visiting Nurse Service of NY.

She currently serves as Executive sponsor of the Syneos Health DE&I Council and is a Director at Large on the Healthcare Businesswomen’s Associations (HBA) Global Board of Directors.

Ms. Keefe holds a B.S. in marketing from Seton Hall University and completed coursework at Wharton Aresty Institute of Executive Education and PDI Ninth House General Management Assessment Center 2012 (now Korn Ferry).

What is Michelle Keefe's net worth?

The estimated net worth of Michelle Keefe is at least $2.56 million as of July 18th, 2022. Ms. Keefe owns 71,266 shares of Syneos Health stock worth more than $2,559,875 as of December 1st. This net worth evaluation does not reflect any other investments that Ms. Keefe may own. Additionally, Ms. Keefe receives a salary of $580,700.00 as Insider at Syneos Health. Learn More about Michelle Keefe's net worth.

How old is Michelle Keefe?

Ms. Keefe is currently 55 years old. There are 6 older executives and no younger executives at Syneos Health. Learn More on Michelle Keefe's age.

What is Michelle Keefe's salary?

As the Insider of Syneos Health, Inc., Ms. Keefe earned a total compensation package of $2,309,774.00 in 2021. Ms. Keefe earned a salary of $567,000.00, stock awards of $1,729,078.00, and other compensation of $13,696.00.There are 3 executives that earn more than Ms. Keefe. The highest earning executive at Syneos Health is Mr. Alistair Macdonald, Advisor, who commands a salary of $1,250,000.00 per year. Learn More on Michelle Keefe's salary.

How do I contact Michelle Keefe?

The corporate mailing address for Ms. Keefe and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected] Learn More on Michelle Keefe's contact information.

Has Michelle Keefe been buying or selling shares of Syneos Health?

Michelle Keefe has not been actively trading shares of Syneos Health during the last quarter. Most recently, Michelle Keefe sold 8,333 shares of the business's stock in a transaction on Monday, July 18th. The shares were sold at an average price of $72.81, for a transaction totalling $606,725.73. Following the completion of the sale, the chief executive officer now directly owns 71,266 shares of the company's stock, valued at $5,188,877.46. Learn More on Michelle Keefe's trading history.

Who are Syneos Health's active insiders?

Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (Insider), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Are insiders buying or selling shares of Syneos Health?

During the last twelve months, insiders at the sold shares 12 times. They sold a total of 29,562 shares worth more than $2,341,080.56. The most recent insider tranaction occured on July, 28th when COO Michael Lee Brooks sold 1,002 shares worth more than $78,156.00. Insiders at Syneos Health own 0.3 % of the company. Learn More about insider trades at Syneos Health.

Information on this page was last updated on 7/28/2022.

Michelle Keefe Insider Trading History at Syneos Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/18/2022Sell8,333$72.81$606,725.7371,266View SEC Filing Icon  
4/15/2021Sell2,736$82.00$224,352.0043,895View SEC Filing Icon  
1/25/2021Sell4,000$75.68$302,720.0052,051View SEC Filing Icon  
11/17/2020Sell800$62.65$50,120.0049,643View SEC Filing Icon  
7/6/2020Sell1,500$59.11$88,665.0050,443View SEC Filing Icon  
5/20/2020Sell2,500$60.00$150,000.0051,943View SEC Filing Icon  
See Full Table

Michelle Keefe Buying and Selling Activity at Syneos Health

This chart shows Michelle Keefe's buying and selling at Syneos Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Syneos Health Company Overview

Syneos Health logo
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Read More

Today's Range

Now: $36.14
Low: $35.00
High: $36.30

50 Day Range

MA: $42.40
Low: $25.70
High: $51.45

2 Week Range

Now: $36.14
Low: $22.89
High: $104.17


13,121 shs

Average Volume

1,999,873 shs

Market Capitalization

$3.72 billion

P/E Ratio


Dividend Yield



Without Graphite, There Would Be ZERO EV Batteries!
Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients.
See This Special Report to Get the Full Story